Author:
Yaghoobi Hamideh,Mohammadi Sahar,Sardashti Samaneh,Abbaspour Seddigheh,Hossein-Abadi Tahere Sarboozi
Abstract
Background:
People with low-mobility are at increased risk for cardiovascular disease. Patients with Parkinson's Disease (PD) are less interested in participating in exercise activities due to the nature of the disease. Regular exercise and physical activity can play protective roles against heart disease by reducing risk factors. This study aimed to compare the effects of aerobic and resistance training on cardiovascular risk factors in women with PD.
Materials and Methods:
This quasi-experimental study was carried out on 45 women with PD who were randomly assigned to one of three groups: aerobic, resistance groups, and control group. Before and after training sessions, variables of weight, Body Mass Index (BMI), heart rate at rest state, maximum oxygen consumption, blood pressure, and lipid profiles of participants were measured. Data were analyzed using SPSS software version 21 and Paired Sample t-test, ANOVA and Bonferroni post-hoc test. A significant level of P≤0.05 was considered.
Results:
Demographics of physiological characteristics of subjects was congruent in all three groups in the baseline. After aerobic and resistance training, levels of triglyceride, LDL, total cholesterol, fat percentage, resting heart rate, weight, BMI and systolic blood pressure were significantly decreased (p<0.05). This change was more pronounced in the aerobic group; in contrast, variables of maximum oxygen consumption and HDL were meaningfully increased in participants of both experimental groups (p<0.05).
Conclusion:
The results showed that both types of aerobic and resistance training can reduce the risk factors of cardiovascular disease in women with PD, while the effect of aerobic training on reducing risk factors was more than resistance training.
Publisher
Bentham Science Publishers Ltd.
Reference41 articles.
1. Mostafavian Z, Gohardehi F, Shakerian S, et al.
Quality of life in patients with Parkinson’s disease: Assessing with the Parkinson’s Disease Questionnaire (PDQ-39).
Majallah-i Ulum-i Pizishki-i Razi
2012;
19
(94)
: 33-9.
Available at: http://jrms.mui.ac.ir/index.php/ jrms/article/view/3978/1852
2. Miller IN, Cronin-Golomb A.
Gender differences in Parkinson's disease: Clinical characteristics and cognition.
Movement Disorders
2010;
15;25
(16)
: 2695-703.
3. DeMaagd G, Philip A.
Parkinson’s disease and its management: part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis.
P&T
2015;
40
(8)
: 504-32.
4. Fereshtehnejad SM, Shafieesabet A, Shafieesabet M, Shahidi GA, Delbari A, Lökk J.
Mortality in iranian patients with Parkinson’s Disease: Cumulative impact of cardiovascular comorbidities as one major risk factor.
Parkinson’s Disease
2015;
2015
5. van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, et al.
Physical inactivity in Parkinson’s disease.
J Neurol
2011;
258
(12)
: 2214-21.